Same Weight Loss, Different Health Gains: What the Keto Trial Found
Three diets each cut about 10% of body weight. Only one produced the biggest liver and blood sugar improvements.
Health News
Sector news category — verified health events only (FDA, guidelines, major studies)
Vaccine News Explained: How to Read Safety and Efficacy Reporting
Trial results get compressed into headlines. Here is what gets lost, and how to read the next one.
FDA Approved Orzeyful, Replacing What Narcolepsy Type 1 Patients Lack
The August 5, 2026 approval of oveporexton brings the first orexin receptor agonist to market — wakefulness restored, not stimulated. What patients should ask.
FDA Approved Lipfendra, the First Oral PCSK9 Inhibitor, for High LDL
The July 15, 2026 approval of enlicitide turns an injection class costing thousands per year into a daily pill. Trial numbers, coverage questions, what's next.
FDA Approved Utebzi, the First Oral Carbapenem, for Complicated UTIs
The June 17, 2026 approval of tebipenem lets some kidney-infection patients leave the infusion chair for a pill — if stewardship rules hold the line on use.
FDA Approved Hepcludex, Closing the US Gap in Hepatitis D Treatment
The May 22, 2026 approval of bulevirtide brings the entry-blocker used in Europe since 2020 to US adults with chronic hepatitis delta. Who should be tested.